Puma Biotechnology (PBYI) Payables (2011 - 2026)
Puma Biotechnology (PBYI) posted Payables of $8.2 million for Q1 2026, up 61.51% on a QoQ basis from $5.1 million in Q4 2025, and up 35.51% year-over-year from $6.0 million in Q1 2025.
Puma Biotechnology (PBYI) Payables (2011 - 2026) Analysis & Trends
Puma Biotechnology's Payables history runs 16 years deep, the most recent figure standing at $8.2 million for Q1 2026.
- Quarterly Payables rose 35.51% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 35.51% YoY) and the FY2025 annual result came in at $5.1 million, down 8.22% from the prior year.
- Payables was $8.2 million for Q1 2026 at Puma Biotechnology, up from $5.1 million in the prior quarter.
- Across five years, Payables topped out at $14.9 million in Q3 2022 and bottomed at $5.1 million in Q4 2025.
- A 5-year average of $7.9 million and a median of $7.4 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables slumped 66.09% — and 2024, when it jumped 73.19%.
- Puma Biotechnology's Payables stood at $6.4 million in 2022, then gained by 6.97% to $6.9 million in 2023, then decreased by 20.03% to $5.5 million in 2024, then declined by 8.22% to $5.1 million in 2025, then soared by 61.51% to $8.2 million in 2026.
- Business Quant data shows PBYI's Payables at $8.2 million in Q1 2026, $5.1 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 8.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.17 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 7.51 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 6.89 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 9.84 Mn |
| Mar 31, 2022 | 7.41 Mn |
| Dec 31, 2021 | 11.17 Mn |
| Sep 30, 2021 | 20.05 Mn |
| Jun 30, 2021 | 11.17 Mn |